Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have all the shares I need now at an average price of 64 cents. Will hold until they are a multi billion dollar market cap company or they accept a buyout bid.
Ok Empery Asset Mgmt you stole shares at 20 cents - now what is your plan to make TPIV go to the moon?
There is unlimited potential to treat rare diseases.
Recent partnership agreement is validation for SMARTICLES. Just a matter of time before it goes on the radar.
Tekmira merger bodes well for Marina.
How can Isis be valued at 8.5 billion and Marina at 18 million?
Wonder if our price target is still $7 now?
This financing sucks! Juno and Kite know how to sell. Our team sucks at selling! This financing is a disgrace and an insult to the science.
Financing screws loyal shareholders and helps new ones. Small biotechs always crap on older shareholders. Only way to deal with these lying cheats is to dollar cost average over years and ignore their lies about how quickly things will develop because they are always off by years.
I will be dollar cost averaging over the next 6 months. The only way to buy these crazy small biotechs.
Would love to see it get to $50. They have great science that could be worth billions in market cap if we have stellar Phase 2 results for breast and ovarian cancer. Need to get off the bulletin board and get a big institution to take an interest.
We need to sell to Wall Street like Juno and Kite. Look at their valuations! Their projects are also in Phase 1 and 2. How do they get that type of valuation?
This company is severely undervalued.
Insider buying would certainly restore confidence in this stock.
Complete disaster. Hope we get bought by a stronger company soon.
Great to see insider buying!
Yes tax loss selling this horrible stock. You are getting in at a great time. I thought last Dec was a great time to get in. Great science. Hope they someday learn how to deliver Phase 1 results.
Congrats on your purchase at 1.75. My cost basis is near $4.50. Love their method of detecting antibodies. I will continue to dollar cost average throughout the next few months. Would love to see them join with a company that addresses immunotherapy with peptide antigens to complement their carbohydrate antigens.
How does Regen use checkpoint blockade ?
Great science but horrible execution and delays.
They should merge with a company like TapImmune.
I think Mayo is a pain in the ass and bureaucratic and slowing down the finalization of Phase 1 results. My opinion based on nothing. But read between the lines and why is Phase 2 going to be with VGTI where Knutson now works?
Maybe they should merge with another immumotherapy company?
Should have waited until Phase 1 data was complete before doing the reverse split. Ruined a new set of investors. Last 12 months have been a complete waste of time to be long this stock.
Google Tom and Christine Ichim and leukemia to learn how their mom passed away due to the disease. They are both extremely motivated to cure leukemia.
There is always the chance for interim Phase 2 data to be released before the end of the 2 year period. Also Knutson will be trying to expedite the Phase 2 trials at VGTI. They will probably move faster than Mayo would have. Also there is the chance we will get some news on the infectious disease side of the business. Could be multiple catalysts but we won't know until it is announced.
It's better that Phase 2 trials will be at VGTI. Probably more innovative and less bureaucratic than Mayo.
A microRNA solution to DMD will be hopefully be superior to other solutions! Nice press release with Rosetta showing progress.
Hopefully they can license TAP or PolyStart to another company in a non strategic indication.
Hopefully funding will come from a partnership in which we receive cash upfront. That would get the stock price up to a respectable level at which they could do a secondary without diluting too much.
MAYBE TAPIMMUNE SHOULD MERGE WITH ANOTHER IMMUNOTHERAPY COMPANY.
MabVax should try to improve upon how antibody drug conjugates are created and try to surpass Seattle Genetics.
MabVax should acquire another immunotherapy company working on vaccines once they get more capital.
I think MabVax should create other nucleic acid carriers for their vaccine products.
I think MabVax is now undervalued given all the IP and Telik assets.
Who knew we had people hell bent on destroying TapImmune? It's a shame. I lost the value of a new house.
Dakota was right back in March. Horrible investment at $5.
Destruction of TapImmune continues. Wish I'd waited a year to invest.
I am not a trader of TPIV. I will hold until the end of Phase 2 testing when the stock price will soar over $30 per share with hopefully positive results for both trials. But if Galena had positive Phase 2 trials with an inferior product, how can TapImmune not have even better Phase 2 results?
What idiot would sell now at these prices when just one thing going right would quadruple the stock price?